




Searching News Database: Neurontin
HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 2 May 2012
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
HSMN NewsFeed - 9 Dec 2010
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
HSMN NewsFeed - 7 Sep 2010
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone(R) Litigation
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone(R) Litigation
HSMN NewsFeed - 4 Jun 2010
Teva Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
Teva Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
HSMN NewsFeed - 18 May 2010
Teva Reaches Settlement Agreement With AstraZeneca Regarding Generic Entocort(R) EC Capsules
Teva Reaches Settlement Agreement With AstraZeneca Regarding Generic Entocort(R) EC Capsules
HSMN NewsFeed - 17 May 2010
Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
HSMN NewsFeed - 9 Mar 2010
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
HSMN NewsFeed - 2 Mar 2010
Teva Announces Favorable Court Ruling in Generic Hyzaar(R) and Cozaar(R) Litigation
Teva Announces Favorable Court Ruling in Generic Hyzaar(R) and Cozaar(R) Litigation
HSMN NewsFeed - 25 Feb 2010
Copaxone(R) 15-Year Study in Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy and Safety
Copaxone(R) 15-Year Study in Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy and Safety
HSMN NewsFeed - 5 Feb 2010
Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
HSMN NewsFeed - 7 Jan 2010
Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec(R) and Nexium(R)
Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec(R) and Nexium(R)
HSMN NewsFeed - 10 Nov 2009
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
HSMN NewsFeed - 16 Sep 2009
Plan B(R) One-Step Emergency Contraception Now Available At U.S. Pharmacies
Plan B(R) One-Step Emergency Contraception Now Available At U.S. Pharmacies
HSMN NewsFeed - 10 Sep 2009
COPAXONE(R) Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients
COPAXONE(R) Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients
HSMN NewsFeed - 28 Apr 2009
Long-Term Study with COPAXONE Indicated Protective Effect on Brain Tissue in Multiple Sclerosis Patients
Long-Term Study with COPAXONE Indicated Protective Effect on Brain Tissue in Multiple Sclerosis Patients
HSMN NewsFeed - 22 Sep 2008
Teva Introduces Nicardipine HCl Injection in the United States; First Alternative to Cardene(R) I.V.
Teva Introduces Nicardipine HCl Injection in the United States; First Alternative to Cardene(R) I.V.
HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
HSMN NewsFeed - 18 Sep 2008
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
HSMN NewsFeed - 30 Apr 2008
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
HSMN NewsFeed - 13 Mar 2008
Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS)
Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS)
HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
HSMN NewsFeed - 6 Feb 2008
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
HSMN NewsFeed - 23 Jan 2008
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
HSMN NewsFeed - 10 Jan 2008
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
HSMN NewsFeed - 16 Sep 2007
Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
HSMN NewsFeed - 4 Sep 2007
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
HSMN NewsFeed - 26 Jun 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
HSMN NewsFeed - 6 Jun 2007
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
HSMN NewsFeed - 10 May 2007
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
HSMN NewsFeed - 11 Feb 2007
Shlomo Yanai Will Assume the Role of Teva's President& CEO on March 1st, 2007
Shlomo Yanai Will Assume the Role of Teva's President& CEO on March 1st, 2007
HSMN NewsFeed - 24 Jan 2007
Teva Files Patent Infringement Complaints Regarding Sertraline Hydrochloride
Teva Files Patent Infringement Complaints Regarding Sertraline Hydrochloride
HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
HSMN NewsFeed - 21 Nov 2006
Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
HSMN NewsFeed - 16 Oct 2006
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed - 10 May 2006
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
Additional items found! 142

Members Archive contains
142 additional stories matching:
Neurontin
(Password required)
Neurontin
(Password required)